These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3228232)

  • 1. Modification of urokinase.
    Shi BZ; Mao GD; Xiong ZP
    Ann N Y Acad Sci; 1988; 542():180-4. PubMed ID: 3228232
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid.
    Chen H; Teramura Y; Iwata H
    J Control Release; 2011 Mar; 150(2):229-34. PubMed ID: 21108976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin binding and zymogenic properties of single-chain urokinase (pro-urokinase).
    Gurewich V; Pannell R
    Semin Thromb Hemost; 1987 Apr; 13(2):146-51. PubMed ID: 3114882
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA).
    Chung DE; Kratz F
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5157-63. PubMed ID: 16875815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen-immobilized urokinase demonstrates increased thrombolytic activity in animal experiments.
    Maksimenko AV; Samarenko MB; Petrov AD; Tischenko EG; Ruda MYa ; Torchilin VP
    Ann N Y Acad Sci; 1990; 613():479-82. PubMed ID: 1706154
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical modification of enzyme molecules to improve their characteristics.
    Cao SG; Zhao QY; Ding ZT; Ma L; Yu T; Wang JH; Feng Y; Cheng YH
    Ann N Y Acad Sci; 1990; 613():460-7. PubMed ID: 2075996
    [No Abstract]   [Full Text] [Related]  

  • 7. The biological activity of antithrombotic agents immobilized on polymer surfaces.
    Kim SW; Ebert CD; McRea JC; Briggs C; Byun SM; Kim HP
    Ann N Y Acad Sci; 1983; 416():513-24. PubMed ID: 6233925
    [No Abstract]   [Full Text] [Related]  

  • 8. Islets surface modification prevents blood-mediated inflammatory responses.
    Teramura Y; Iwata H
    Bioconjug Chem; 2008 Jul; 19(7):1389-95. PubMed ID: 18533707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of urokinase.
    Tajima H; Ishiguro J; Nonaka R; Kurita M; Tanaka S
    Chem Pharm Bull (Tokyo); 1974 Apr; 22(4):727-35. PubMed ID: 4418203
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
    Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
    Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of immobilized enzymes for biomaterials used in surgery.
    Watanabe S; Shimizu Y; Teramatsu T; Murachi T; Hino T
    Methods Enzymol; 1988; 137():545-51. PubMed ID: 3374358
    [No Abstract]   [Full Text] [Related]  

  • 12. Immobilized urokinase column as part of a specific detection system for plasminogen species separated by high-performance affinity chromatography.
    Abe I; Ito N; Noguchi K; Kazama M; Kasai K
    J Chromatogr; 1991 Apr; 565(1-2):183-95. PubMed ID: 1874866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of urokinase immobilized to cross-linked poly(2-hydroxyethyl methacrylate).
    Liu LS; Ito Y; Imanishi Y
    Biomaterials; 1991 Aug; 12(6):545-9. PubMed ID: 1772951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of urokinase by affinity chromatography.
    Holmberg L; Bladh B; Astedt B
    Biochim Biophys Acta; 1976 Aug; 445(1):215-22. PubMed ID: 953032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator.
    Nolli ML; Corti A; Soffientini A; Cassani G
    Thromb Haemost; 1986 Oct; 56(2):214-8. PubMed ID: 2433787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the plasminogen activator urokinase by alpha-tocopherol.
    Ogston D
    Acta Haematol; 1982; 67(2):114-8. PubMed ID: 6801892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of urokinase-treated material.
    Ohshiro T; Liu MC; Kambayashi J; Mori T
    Methods Enzymol; 1988; 137():529-45. PubMed ID: 3131632
    [No Abstract]   [Full Text] [Related]  

  • 19. Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase.
    Reith A; Rucklidge GJ
    Biochem Biophys Res Commun; 1992 Jul; 186(1):348-54. PubMed ID: 1321608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the activation of pro-urokinase by thermolysin.
    Marcotte PA; Henkin J
    Biochim Biophys Acta; 1993 Jan; 1161(1):105-12. PubMed ID: 8422417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.